Your browser doesn't support javascript.
loading
Intensive Blood Pressure Lowering in Patients With Malignant Left Ventricular Hypertrophy.
Ascher, Simon B; de Lemos, James A; Lee, MinJae; Wu, Elaine; Soliman, Elsayed Z; Neeland, Ian J; Kitzman, Dalane W; Ballantyne, Christie M; Nambi, Vijay; Killeen, Anthony A; Ix, Joachim H; Shlipak, Michael G; Berry, Jarett D.
Afiliação
  • Ascher SB; Kidney Health Research Collaborative, Department of Medicine, San Francisco Veterans Affairs Health Care System and University of California-San Francisco, San Francisco, California, USA; Division of Hospital Medicine, University of California-Davis, Sacramento, California, USA. Electronic address:
  • de Lemos JA; Divison of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Lee M; Division of Biostatistics, Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Wu E; Divison of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • Soliman EZ; Epidemiological Cardiology Research Center, Department of Epidemiology and Prevention, Division of Public Health Sciences and Department of Medicine, Section on Cardiology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
  • Neeland IJ; University Hospitals Harrington Heart and Vascular Institute and Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Kitzman DW; Sections of Cardiology and Gerontology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
  • Ballantyne CM; Department of Medicine and Center for Cardiometabolic Disease Prevention, Baylor College of Medicine, Houston, Texas, USA.
  • Nambi V; Department of Medicine and Center for Cardiometabolic Disease Prevention, Baylor College of Medicine, Houston, Texas, USA; Department of Medicine, Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, USA.
  • Killeen AA; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA.
  • Ix JH; Nephrology Section, Veterans Affairs San Diego Healthcare System, San Diego, California, USA; Division of Nephrology-Hypertension, University of California-San Diego, San Diego, California, USA.
  • Shlipak MG; Kidney Health Research Collaborative, Department of Medicine, San Francisco Veterans Affairs Health Care System and University of California-San Francisco, San Francisco, California, USA.
  • Berry JD; Department of Internal Medicine, University of Texas at Tyler Health Science Center, Tyler, Texas, USA.
J Am Coll Cardiol ; 80(16): 1516-1525, 2022 10 18.
Article em En | MEDLINE | ID: mdl-36229087
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca / Hipertensão Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Insuficiência Cardíaca / Hipertensão Tipo de estudo: Clinical_trials / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Am Coll Cardiol Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos